KL1 Stock Overview
Pathway Health Corp. operates medical clinics in Canada. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Pathway Health Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.006 |
| 52 Week High | CA$0.045 |
| 52 Week Low | CA$0.006 |
| Beta | -0.22 |
| 1 Month Change | 0% |
| 3 Month Change | -40.00% |
| 1 Year Change | -78.57% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -95.88% |
Recent News & Updates
Recent updates
Shareholder Returns
| KL1 | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | 0% | -3.8% | -2.0% |
| 1Y | -78.6% | 15.6% | 6.9% |
Return vs Industry: KL1 underperformed the German Healthcare industry which returned 10.6% over the past year.
Return vs Market: KL1 underperformed the German Market which returned 5.9% over the past year.
Price Volatility
| KL1 volatility | |
|---|---|
| KL1 Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 4.7% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 11.3% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: KL1's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine KL1's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 91 | n/a | www.pathwayhealth.ca |
Pathway Health Corp. operates medical clinics in Canada. The company owns and operates community-based clinics across five provinces that offer multi-disciplinary therapies to patients that suffer from chronic pain. It also provides medical cannabis services.
Pathway Health Corp. Fundamentals Summary
| KL1 fundamental statistics | |
|---|---|
| Market cap | €1.29m |
| Earnings (TTM) | -€6.21m |
| Revenue (TTM) | €6.75m |
0.2x
P/S Ratio-0.2x
P/E RatioIs KL1 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| KL1 income statement (TTM) | |
|---|---|
| Revenue | CA$9.85m |
| Cost of Revenue | CA$5.04m |
| Gross Profit | CA$4.81m |
| Other Expenses | CA$13.87m |
| Earnings | -CA$9.06m |
Last Reported Earnings
Mar 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.097 |
| Gross Margin | 48.82% |
| Net Profit Margin | -91.97% |
| Debt/Equity Ratio | -89.0% |
How did KL1 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/10/25 23:57 |
| End of Day Share Price | 2023/07/28 00:00 |
| Earnings | 2023/03/31 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Pathway Health Corp. is covered by 0 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|